Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1222
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials

Korean Journal of Radiology
Nuclear MedicineRadiologyImaging
2020English

Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance

Immunity
Infectious DiseasesAllergyImmunology
2013English

Metal-Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics

European Journal of Inorganic Chemistry
Inorganic Chemistry
2016English

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence From Clinical Trials

Medicina
Medicine
2019English

A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies

Oncologist
Cancer ResearchMedicineOncology
2020English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

NCCN Working Group Report: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials

Dermatology and Therapy
Dermatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy